Rewriting the Trial Script: Digital and Decentralized Pharmacological Research
Keywords:
Decentralized Clinical Trials, Mobile Health, Blockchain, Remote Monitoring, AI in Pharmacology, Regulatory Harmonization, Digital ConsentAbstract
The transition to decentralized clinical trials (DCTs) reflects a paradigm shift in pharmacological research. Powered by telemedicine, artificial intelligence (AI), wearables, mobile health (mHealth), and blockchain, DCTs enable remote recruitment, consent, monitoring, and data analysis. This review consolidates current methodologies, emerging innovations, global regulatory adaptations, and real-world case applications. Emphasizing equity, ethics, interoperability, and patient engagement, this paper serves as a comprehensive roadmap for integrating decentralized research into clinical pharmacology.